Clinical Trial Update: First-time-in-Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single (in Both Fed and Fasted States) or Repeat Doses of GSK3358699 [Phase 1]

View source ↗

Summary

Phase 1 first-in-human study of GSK3358699 assessing safety, tolerability, PK/PD in single and repeat dosing (fed/fasted) in rheumatoid arthritis; the trial is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• GSK3358699

Snippet

Sponsor: GlaxoSmithKline | Conditions: Arthritis, Rheumatoid | Phase 1 | Status: TERMINATED | Results posted: 2020-12-02